CAMK2D Protein, Human (Sf9, GST)

CAMK2D protein regulates calcium levels and excitation-contraction coupling in the heart. CAMK2D Protein, Human (Sf9, GST) is the recombinant human-derived CAMK2D protein, expressed by Sf9 insect cells , with N-GST labeled tag. The total length of CAMK2D Protein, Human (Sf9, GST) is 498 a.a., .

CAMK2D protein, a calcium/calmodulin-dependent protein kinase, intricately regulates Ca(2+) homeostasis and excitation-contraction coupling (ECC) in the heart by targeting a spectrum of ion channels, transporters, and accessory proteins involved in various facets of Ca(2+) dynamics within the myocyte. It plays a pivotal role in Ca(2+) influx, release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake, and the transport of Na(+) and K(+) channels. Additionally, CAMK2D targets transcription factors and signaling molecules to finely regulate heart function. In its activated form, it is implicated in the pathogenesis of dilated cardiomyopathy and heart failure, contributing to cardiac decompensation by directly phosphorylating the RYR2 Ca(2+) channel on 'Ser-2808' to regulate SR Ca(2+) release. In the nucleus, CAMK2D phosphorylates the MEF2 repressor HDAC4, promoting nuclear export and binding to 14-3-3 protein, thus influencing the expression of MEF2 and hypertrophic program-related genes. Essential for left ventricular remodeling responses to myocardial infarction, CAMK2D acts downstream of the beta-adrenergic receptor signaling cascade to regulate key proteins involved in ECC during pathological myocardial remodeling. It also targets and regulates the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K(+) channel Kv4.3/KCND3, contributing to arrhythmogenesis in heart failure. Moreover, CAMK2D phosphorylates phospholamban (PLN/PLB), enhancing SR Ca(2+) uptake, and may participate in the modulation of skeletal muscle function in response to exercise. Additionally, in response to interferon-gamma (IFN-gamma) stimulation, CAMK2D catalyzes the phosphorylation of STAT1, thereby stimulating the JAK-STAT signaling pathway.

Human

Sf9 insect cells

N-GST

Q13557 (A2-I499)

817

Greater than 90% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.